Skip to content
Search

Latest Stories

Debt soars as pharmacies fight closure: Industry voices concern over pharmacy minister's statements

Debt soars as pharmacies fight closure: Industry voices concern over pharmacy minister's statements

While official statements paint a picture of a resilient pharmacy sector, industry stakeholders raise concerns about the disconnect between rhetoric and reality

Pharmacy Minister Dame Andrea Leadsom has sparked controversy with her recent remarks during the final session of the Health and Social Care Committee's (HHSC) Pharmacy Inquiry on Monday.


Despite acknowledging the closure of nearly 400 pharmacies since the beginning of the 2023/24 financial year, Dame Andrea asserted that the community pharmacy sector remains robust, describing it as a "thriving market."

At the session she attributed the changing landscape to the natural evolution of the market and assured that "access to pharmacy services remains unaffected", suggesting patients turn to online distance selling pharmacies if faced with closures or temporary inconveniences.

Highlighting the government's stance on pharmacy closures, she stressed that "pharmacies operate as private businesses", with the government refraining from intervening in closure decisions.

Instead, local councils and integrated care boards are tasked with assessing pharmaceutical needs and facilitating the opening of new pharmacies.

Dr. Amanda Doyle from NHS England echoed Dame Andrea's sentiments, acknowledging a shift in the sector's composition with a decline in brick-and-mortar pharmacies.

However, she addressed a simultaneous rise in distance selling pharmacies and stressed "to increase the role of community pharmacy as a first line provider of clinical services to the community."

However, industry figures have criticised the comments, labelling them as "out of touch with the reality faced by pharmacies" across England.

Leyla Hannbeck, CEO of Association of Independent Multiple Pharmacies (AIMP), expressed concern over the crisis gripping the sector, citing closures, overwork, and severe underfunding.

She emphasised that "independent pharmacies primarily rely on NHS activities and are crucial healthcare providers, especially in deprived areas".

Ian Strachan, Owner of Strachan’s Pharmacy Group, echoed these sentiments, pointing to "compelling evidence of pharmacies accumulating debt".

He criticised the minister's apparent indifference towards "mounting debt and closures", attributing the profession's struggles to their dedication to patient care.

Despite assertions from government officials regarding the sector's resilience, industry insiders argue that the reality paints a bleaker picture.

With closures on the rise and financial pressures mounting, the future of community pharmacies remains uncertain, prompting calls for urgent intervention to safeguard vital healthcare services.

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less